Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...

According to a new major clinical trial known as the ESSENCE trial, semaglutide—better known as Ozempic when used for Type 2 ...

Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...

A MOTHER has revealed that she was unhappy and overweight so decided to start using Mounjaro. In just seven months, thanks to ...

Q. I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were all out of stock.

A MUM who lost a whopping 3.5st in just two months thanks to Mounjaro has revealed she finally feels happy despite having ...

President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Novo Nordisk stock jumped more than 2% in trading Wednesday after beating Wall Street's profit estimates for the first ...

Hims & Hers continues to deliver strong revenue growth. Meanwhile, the company surprised investors by offering a long-term ...

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...